• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Vascular permeability factor mRNA and protein expression in human kidney.

作者信息

Brown L F, Berse B, Tognazzi K, Manseau E J, Van de Water L, Senger D R, Dvorak H F, Rosen S

机构信息

Department of Pathology, Beth Israel Hospital, Boston, Massachusetts.

出版信息

Kidney Int. 1992 Dec;42(6):1457-61. doi: 10.1038/ki.1992.441.

DOI:10.1038/ki.1992.441
PMID:1474780
Abstract

Vascular permeability factor (VPF), also known as vascular endothelial growth factor (VEGF), is a potent microvascular permeability-enhancing mediator as well as a selective mitogen for vascular endothelium. In this study, in situ hybridization and immunohistochemistry co-localized VPF mRNA and protein to glomerular visceral epithelial cells in human kidneys. Northern analysis confirmed the presence of VPF mRNA of expected size. The finding of VPF in renal glomerular epithelium identifies a potent mediator of permeability and endothelial proliferation whose role in renal physiology and pathology requires investigation.

摘要

相似文献

1
Vascular permeability factor mRNA and protein expression in human kidney.
Kidney Int. 1992 Dec;42(6):1457-61. doi: 10.1038/ki.1992.441.
2
Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases.血管通透性因子(VPF/VEGF)的表达在许多肾小球疾病中会发生改变。
J Am Soc Nephrol. 1996 May;7(5):661-6. doi: 10.1681/ASN.V75661.
3
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer.血管通透性因子(血管内皮生长因子)及其受体在乳腺癌中的表达
Hum Pathol. 1995 Jan;26(1):86-91. doi: 10.1016/0046-8177(95)90119-1.
4
Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor.人肾小球系膜细胞和外周血单核细胞产生血管通透因子。
Kidney Int. 1993 Nov;44(5):959-66. doi: 10.1038/ki.1993.337.
5
Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells.血管紧张素II刺激人系膜细胞中血管通透性因子/血管内皮生长因子的合成与分泌。
J Am Soc Nephrol. 1999 Feb;10(2):245-55. doi: 10.1681/ASN.V102245.
6
Expression of vascular endothelial growth factor and its receptors in rats with protein-overload nephrosis.血管内皮生长因子及其受体在蛋白超负荷肾病大鼠中的表达
Nephrol Dial Transplant. 1998 Oct;13(10):2519-28. doi: 10.1093/ndt/13.10.2519.
7
Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues.血管通透性因子/血管内皮生长因子在正常大鼠组织中的表达
Am J Physiol. 1993 Apr;264(4 Pt 1):C995-1002. doi: 10.1152/ajpcell.1993.264.4.C995.
8
Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cells: possible involvement in the development of edema in chronic inflammation.浆细胞表达血管通透性因子(VPF/VEGF)信使核糖核酸:可能参与慢性炎症中水肿的形成。
Pathol Int. 1995 Oct;45(10):715-20. doi: 10.1111/j.1440-1827.1995.tb03387.x.
9
Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.通过抑制血管内皮生长因子受体酪氨酸激酶磷酸化治疗人肺腺癌恶性胸腔积液
Clin Cancer Res. 2000 Mar;6(3):957-65.
10
Serum and platelet-derived growth factor-induced expression of vascular permeability factor mRNA by human vascular smooth muscle cells in vitro.血清和血小板衍生生长因子体外诱导人血管平滑肌细胞表达血管通透因子mRNA 。
Clin Sci (Lond). 1995 Feb;88(2):141-7. doi: 10.1042/cs0880141.

引用本文的文献

1
Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives.健康与疾病中的血管内皮生长因子信号传导:从分子机制到治疗前景
Signal Transduct Target Ther. 2025 May 19;10(1):170. doi: 10.1038/s41392-025-02249-0.
2
Unraveling the Complex Molecular Interplay and Vascular Adaptive Changes in Hypertension-Induced Kidney Disease.解析高血压诱导的肾脏疾病中复杂的分子相互作用和血管适应性变化。
Biomedicines. 2024 Aug 1;12(8):1723. doi: 10.3390/biomedicines12081723.
3
A half-century of VEGFA: from theory to practice.
VEGFA的半个世纪:从理论到实践。
J Clin Invest. 2024 Aug 1;134(15):e184205. doi: 10.1172/JCI184205.
4
Pro- and anti-fibrotic effects of vascular endothelial growth factor in chronic kidney diseases.血管内皮生长因子在慢性肾脏病中的抗纤维化和促纤维化作用。
Ren Fail. 2022 Dec;44(1):881-892. doi: 10.1080/0886022X.2022.2079528.
5
Targeting angiogenesis and lymphangiogenesis in kidney disease.靶向肾脏疾病中的血管生成和淋巴管生成。
Nat Rev Nephrol. 2020 May;16(5):289-303. doi: 10.1038/s41581-020-0260-2. Epub 2020 Mar 6.
6
Biomarkers associating endothelial Dysregulation in pediatric-onset systemic lupus erythematous.与儿童起病系统性红斑狼疮内皮失调相关的生物标志物。
Pediatr Rheumatol Online J. 2019 Oct 24;17(1):69. doi: 10.1186/s12969-019-0369-7.
7
Pro-angiogenic therapeutics for preeclampsia.用于子痫前期的促血管生成治疗方法。
Biol Sex Differ. 2018 Aug 25;9(1):36. doi: 10.1186/s13293-018-0195-5.
8
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254).一项舒尼替尼治疗持续性或复发性透明细胞卵巢癌的 II 期评估:NRG 肿瘤学/妇科肿瘤学组研究(GOG-254)。
Gynecol Oncol. 2018 Aug;150(2):247-252. doi: 10.1016/j.ygyno.2018.05.029. Epub 2018 Jun 18.
9
Antiangiogenic Therapy for Diabetic Nephropathy.抗血管生成治疗糖尿病肾病。
Biomed Res Int. 2017;2017:5724069. doi: 10.1155/2017/5724069. Epub 2017 Aug 1.
10
Assessment of Serum Vascular Endothelial Growth Factor Levels in Pregnancy-Induced Hypertension Patients.妊娠高血压患者血清血管内皮生长因子水平的评估
J Pregnancy. 2017;2017:3179670. doi: 10.1155/2017/3179670. Epub 2017 Jan 4.